Delivery Order SPE2DB22D1106-SPE2DB25FERM9
Award Date
6/3/25
Potential Completion Date
6/4/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $1,373.88 and a period of performance through April 30, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM medication. The contract has a Firm Fixed Price pricing type, a ceiling value of $1,515.72, and an ultimate completion date of October 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,055.96, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a medication used to treat respiratory conditions. The contract is a firm-fixed-price delivery order with a performance period ending on May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a respiratory medication, and has a firm fixed price of $9,139.54 and a completion date of April 11, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 80-4.5 10.2GM, a prescription medication, with a ceiling value of $2,536.62 and a period of performance through April 11, 2025. The contract is a firm fixed-price delivery order, which indicates it is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a prescription medication, with a ceiling value of $1,136.79 and a performance period ending on September 17, 2024. This contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,953.46, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The contract is a firm fixed-price delivery order with a performance period that extends through May 6, 2025. This contract is not set aside for any specific...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,210.56, is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a respiratory medication, with a final delivery date of December 12, 2023. The contract is structured as a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen also holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a firm fixed price of $1,514.64 and a completion date of April 21, 2025. The contract is not designated as a set-aside and is an open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,472.41, is for the delivery of the medication Budesonide-Formoterol 80-4.5 10.2GM. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...